second-line pharmacological treatmentBrain-Gut Behavioural TherapiesIrritable bowel syndromeIBS
…ent with ethnic minority patients less likely to be recommended second-line pharmacological treatment (27.9% vs. 8.8%, P=0.004) and Brain-Gut Behavioural Therapies (…